The turnaround is earnings quality, not AUM alone
Reported Q2 PAT 50.7, proposed merger accounting pending.
Watch: WATCH; verify cash earnings and statutory reset.
Home / Research / UGRO Capital Limited
The turnaround is earnings quality, not AUM alone
https://nsearchives.nseindia.com/corporate/UGROCAP_13112026120914_CoverLetterTranscriptSigned.pdf
https://nsearchives.nseindia.com/corporate/UGROCAP_13112026120914_CoverLetterTranscriptSigned.pdf
https://nsearchives.nseindia.com/corporate/UGROCAP_13112026120914_CoverLetterTranscriptSigned.pdf
https://nsearchives.nseindia.com/corporate/UGROCAP_13112026120914_CoverLetterTranscriptSigned.pdf
Reported Q2 PAT 50.7, proposed merger accounting pending.
Watch: WATCH; verify cash earnings and statutory reset.
Q2 total 3,159, +24% QoQ.
Watch: Separate new book and run-off.
H1 118.6, Q2 50.7, inferred Q1 67.9.
Watch: Reconcile tax and accounting items.
53% vs 32% Dec 2025; 85% FY29 goal.
Watch: Track credit quality and cash contribution.
SAGE PRO Institutional Equity Research | 16 November 2026 | NSE: UGROCAP | Q2 FY2027 (30 September 2026)
Stance: WATCH — potentially asymmetric turnaround, unusually high accounting and execution risk. Horizon 12–36 months. Reference close ₹65.72, 13 November 2026 (Sage PRO canonical price). All amounts ₹ crore unless noted. Q2 and Q1 FY27 figures are consolidated and include Profectus Capital and GROx Technologies; Q2 FY26 was standalone. Pro forma merger metrics are management estimates subject to NCLT sanction and auditor review, not reported statutory numbers. The original source-ledger, financial basis and limitations are explicit.
Key takeaways
This is a potentially material change in economic quality, not merely a new product label.
Q2 net disbursement ₹3,159 crore (+77% YoY, +24% QoQ), AUM ₹15,019 crore (flat QoQ by design, +23% YoY), focus businesses ₹7,929 crore or 53% of AUM, reported PBT ₹68.3 crore and PAT ₹50.7 crore. [A,B, pp.2–5] Management's stated FY29 target is 3–3.5% ROA, growth without new equity for three years and focus businesses 85% of AUM.
These are management commitments, not model outputs or completed results. The company has evidence of a real portfolio shift; the unresolved question is whether the new high-yield segments produce durable cash-adjusted returns after credit costs and platform commissions.
Variant thesis: if actual loan tenure is reflected more conservatively in the accounting, upfront income reversals decline and the direct/merchant loan engines deliver better risk-adjusted contribution, valuation may shift from a low-confidence book-value discount to a recurring earnings lens. Counter-thesis: the accounting reset reduces reported book, the merger remains conditional, and rapidly growing merchant credit may produce delayed stress. The apparent discount to book can be a rational risk discount rather than a mispricing. We do not recommend purchasing merely because the current price is below reported book.
| Management-reported metric | Q2 FY27 | Comparison / qualification |
|---|---|---|
| AUM | 15,019 | +23% YoY, broadly flat QoQ; consolidated comparison with standalone prior year |
| Net disbursement | 3,159 | +77% YoY / +24% QoQ |
| On-book loans | 9,693 | 9,519 June; +1.8% |
| PBT | 68.3 | +12% YoY / +11% QoQ, different prior-year scope |
| PAT | 50.7 | +17% YoY; H1 ₹118.6 crore |
| Operating cost | 127 | 205 Q4 FY26 (management comparison) |
| Portfolio yield | 18.7% | +108bp YoY |
| GNPA / collection efficiency | 2.7% / 97% | Issuer metrics |
| Capital adequacy | 18.8% | Standalone reported; ~22% merged pro forma |
| Pro forma ROA | 2.1% Q2 | 2.7% H1; not statutory |
Source [A,B]. Q2 FY26 standalone and Q2 FY27 consolidated differ in scope; growth rates are issuer-reported and must not be described as organic. H1 consolidated PAT 118.6 less Q2 50.7 implies Q1 reported PAT 67.9.
Q2 reported PAT declined ~25.3% QoQ despite higher PBT per management, which requires tax/non-operating/accounting reconciliation. Do not claim a clean sequential PAT acceleration. The approximate Q1 PBT implied from 11% growth is 61.5, lower than inferred Q1 PAT; this illustrates why non-recurring items and scope must be examined through statutory accounts rather than force an ordinary tax bridge.
Q2 PAT/PBT is ~74.2%, not a full normalized tax model.
Key takeaways
[B] The important point is funding and earnings risk: a loan can remain in managed AUM while its contractual cash flows, recognition and retained risk differ substantially from a wholly on-book loan.
The cost reduction from ₹205 crore Q4 FY26 to ₹127 crore Q2 is ₹78 crore or ~38%, according to management's comparative series. This is meaningful, but establish like-for-like consolidation and one-time restructuring items.
The issuer targets about ₹220 crore annual cost takeout and approximately ₹490 crore FY27 operating cost in its discussion. A quarterly run rate 127 × 4 = 508 is not the full-year actual, and seasonal/restructuring effects matter.
Require sustainable branch and platform productivity rather than annualizing the most favorable comparison.
Key takeaways
[B, pp.3–4] This is a material quality-of-earnings issue. Reversals are not necessarily loan losses; rather, they can represent previously recognized income that will not be earned. Good borrower repayment behavior can paradoxically reduce reported earnings when projected life exceeds actual life.
The key lesson is that originator economics should be modeled using observed behavioral tenure, cash receipts, funding and realized losses. Contractual maturity is not expected life. For an illustrative ₹100 crore of co-originated assets with expected net spread 2% annually, projecting three years versus one and a half years produces roughly ₹6 crore versus ₹3 crore undiscounted future spread before fees, repayment profile, risk or discounting; recognizing too much upfront can create a later reversal even if principal is fully recovered.
This is an explanatory illustration, not UGRO's actual contract.
Management further explained that such recognized upfront income did not fully add to regulatory capital until cash realization. A capital-light origination structure can therefore appear profitable without generating enough deployable regulatory equity. This distinction is important for an NBFC with a history of capital raises: statutory equity, regulatory capital and cash earnings are not interchangeable.
The proposed Profectus merger would remeasure co-lending and assignment income on behavioral rather than contractual life, and management proposes one-time adjustments including goodwill/acquisition costs against reserves, subject to NCLT sanction and auditor review. The pro forma equity bridge reported net worth ~2,454 crore or ~₹158/share versus reported book ~₹195/share.
[A,B, slides 13–14] That is ~19% reduction per share; it is material to valuation. Management states those items were already deducted from Tier 1, hence the adjustment would not reduce regulatory capital in the same way, and removal of investment deduction may raise capital adequacy toward ~22%.
This is management's proposed treatment, not an approved accounting restatement. Require final court order, statutory auditor-reviewed financial statements, actual share count and opening balance-sheet reconciliation.
The final NCLT hearing was scheduled for 20 November 2026 per the November 6 call; as of report cutoff, outcome is not assumed.
| AUM grouping | December 2025 | September 2026 | Change |
|---|---|---|---|
| Emerging-market LAP | 3,199 | 4,268 | +33.4% |
| GROx | 1,798 | 3,661 | +103.6% |
| Defocused book | 10,458 | 7,090 | −32.2% |
| Focus businesses share | ~32% | ~53% | +21 percentage points |
[A,B, slides 9–12]. AUM sum September 4,268 + 3,661 + 7,090 = 15,019; focus share 7,929/15,019 = 52.8%. December sum 15,455 and focus 4,997 = 32.3%. The total stock has decreased modestly across these endpoints while the desired book grew substantially. That is exactly why aggregate AUM growth is currently a misleading measure of operating progress. The old book run-off can mask new segment originations; it may also release funding/capital and reduce lower-yield exposure.
Key takeaways
Collateral title, legal enforcement, local property liquidity, informal borrower cash flow and field collections matter. High yield provides room for costs and losses, but LTV up to 75% is a maximum, not mean portfolio LTV; do not infer all loans have 25% collateral buffer.
Average monthly disbursement per branch rose from ~₹48 lakh FY26 to ₹62 lakh Q1 and ₹73 lakh Q2; branches older than 12 months ~₹86 lakh per month. [B] This is evidence that the build-out may deliver operating leverage as branches mature. Yet increasing disbursement per branch is valuable only if later loss and collections do not worsen. Track matured branch cohorts separately from recent locations, productivity after credit loss, and new-market concentration.
GROx AUM ₹3,661 crore, +22% QoQ, embedded in payment and merchant ecosystems; management refers to ~4.1 lakh active merchants/customers across partner platforms. [B] A digital channel can improve acquisition and use transaction data for underwriting, but the platform partner's customer ownership, revenue-sharing, data permission, fraud controls and collections determine economics.
Growth from ₹1,798 crore in nine months is rapid; short-tenor lending can reveal initial repayment issues sooner, but repeat lending may hide refinancing or borrower leverage. Require cohort vintage loss and repeat loan quality, not gross disbursements.
Merchant dependence on seasonal sales and partner traffic creates correlated risks.
The combined focus book is deliberately different: secured longer-tenor property credit and granular embedded merchant credit. Diversification can improve economic resilience if losses are not correlated; a weak local economy or merchant turnover can affect both. Track secured and unsecured loss curves independently and total customer/partner exposure. Do not apply gold or home-loan NPA benchmarks to these products.
Key takeaways
Funding flexibility depends on actual retained cash earnings and off-book risk transfer. If direct on-book lending scales faster, even a higher yield can require more funding and equity. Capital-light partnership arrangements should be assessed on regulatory deductions, retained loss sharing, servicing obligations and liquidity commitments, not simply headline AUM.
A 50bp annual credit cost increase applied illustratively to on-book ₹9,693 crore equates to ₹48.5 crore pre-tax—nearly the Q2 quarterly PAT. Annualized Q2 PBT 273.2 means sensitivity ~18% of annualized pre-tax earnings; actual average financed assets and off-book retained risk differ.
Management claims no new equity for three years; this is a commitment conditional on earnings, growth, risk weights and merger treatment. It must be tested every quarter against capital adequacy, liquidity, partner funding and cash-realized retained profit.
Never assume the company will avoid dilution merely because reported accounting equity is reduced against reserves. The proposed merger is a key binary catalyst and a reporting transition risk; court approval and restated statements are distinct events.
Key takeaways
The company cited end-October market value ₹1,130 crore and pro forma equity ~₹2,454 crore (~0.46x), using its own earlier reference date. Do not combine the earlier market cap with later stock price without shares. A discount to adjusted equity is potentially attractive only if that equity is recoverable and earns its hurdle. Goodwill, unearned income adjustments and loan losses can alter book further.
Illustrative normalized earnings: closing on-book loans ₹9,693 crore, average next-year on-book assets = closing × (1 + growth/2) with bear/base/bull growth 5%/20%/35%. Assumed after-tax profit/average on-book assets 1.5%/2.5%/3.3% gives PAT ~149/267/376 crore.
This proxy does not forecast total statutory ROA, off-book income, acquisitions, capital changes or group earnings; it is a sensitivity of on-book loan earning power. Compare these to Q2 reported annualized PAT ₹202.8 crore and management pro forma ROA only with correct denominator.
| Case | Assumed growth | After-tax return on avg on-book assets | Illustrative PAT ₹cr |
|---|---|---|---|
| Bear | 5% | 1.5% | 149 |
| Base | 20% | 2.5% | 267 |
| Bull | 35% | 3.3% | 376 |
On proposed adjusted equity ₹2,454 crore, these imply simple closing-equity return proxies ~6.1%/10.9%/15.3%. At 14% required return, annual economic profit is approximately −195/−77/+32 crore. In other words, the base turnaround can improve profit but still fail to earn a risk-adjusted cost of equity.
A justified terminal P/B formula with 11% ROE, 14% cost and 5% growth gives ~0.67x; if ROE stays 6% and cost 15% with 3% growth, ~0.25x; at 15% ROE, 13% cost and 6% growth, ~1.29x. These are scenarios, not target prices.
There may be meaningful upside if the turnaround is proven and the adjusted book is sound, but a loss scenario can justify a discount even at today's price.
Peer comparisons should include secured MSME specialists (Five-Star, SBFC, MAS) and diversified partner/digital lenders (Northern Arc), with differences in product mix, capital, tenure, default definitions and cash income recognition. No peer multiple ranking is issued until same-date statutory attributable earnings/book and merger share count are independently matched.
| Test | Q2 evidence | Required next evidence |
|---|---|---|
| New mix | 53% focus; 85% FY29 objective | Focus growth with cash yield and stable cohort losses |
| Old book | ₹7,090cr; −32% in nine months | Actual runoff, prepayment reversal, release of capital |
| Accounting | ₹318cr past reversal; proposed ₹158 BV | NCLT order, audited restatement, behavioral-tenure policy |
| Branch | ₹73 lakh/month average Q2 | Mature branch risk-adjusted contribution |
| GROx | ₹3,661cr; +22% QoQ | Vintage loss, partner concentration, repeat borrowing |
| Cost | ₹127cr quarter vs ₹205cr Q4 comparator | Actual like-for-like sustainable expense |
| Capital | 18.8% standalone; ~22% pro forma | Actual post-merger CAR, cash capital and funding |
| Earnings | ₹50.7cr Q2 reported PAT; ~2.1% pro forma ROA | Reconcile statutory vs pro forma; cash-adjusted ROA |
Catalysts: the scheduled November 20 NCLT hearing and subsequent order if granted; complete audited restatement; evidence of recurring cash earnings with lower reversal; stable GROx/LAP losses; FY27 cost and capital delivery. Thesis breakers: delayed or materially adverse merger/accounting outcome, further book write-down, higher new-vintage delinquency, partner funding withdrawal, or need for new equity despite stated plan. Maintain WATCH and require final statutory results before interpreting adjusted P/B as an investment opportunity.
https://nsearchives.nseindia.com/corporate/UGROCAP_13112026120914_CoverLetterTranscriptSigned.pdf
https://nsearchives.nseindia.com/corporate/UGROCAP_13112026120914_CoverLetterTranscriptSigned.pdf
https://nsearchives.nseindia.com/corporate/UGROCAP_13112026120914_CoverLetterTranscriptSigned.pdf
https://nsearchives.nseindia.com/corporate/UGROCAP_13112026120914_CoverLetterTranscriptSigned.pdf
This is dated research, not a live market quote. Scenarios and historical performance are not guarantees.